Exploring Hemophilia-Specific Recruitment Challenges

Time: 11:30 am
day: Day One

Details:

  • Discussing eligibility of patients with neutralizing antibodies to the proposed AAV vector
  • Evaluating how the number of hemophilia clinical trials impacts recruitment
  • Determining whether current treatment is adequate for the hemophilia community

Speakers: